Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Development

Weight Loss Treatments

Metsera Backs Pfizer’s $10 Billion Deal, Citing Regulatory Risks in Novo Bid

FTC concerns over Novo’s two-step structure made Pfizer’s revised offer the board’s preferred path.

Pfizer to Buy Metsera for $4.9 Billion Upfront in Return to Obesity Drugs